The orally bioavailable met inhibitor PF‐2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model

Sampson, Erik R ; Martin, Brad A ; Morris, Aimee E ; Xie, Chao ; Schwarz, Edward M ; O'Keefe, Regis J ; Rosier, Randy N

Journal of bone and mineral research, 2011-06, Vol.26 (6), p.1283-1294 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível